{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:13:41Z","timestamp":1794896021451,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]},{"name":"Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Project","award":["KAZ-T-NCTP No. 3101"],"award-info":[{"award-number":["KAZ-T-NCTP No. 3101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study examined the treatment outcomes of multidrug-resistant tuberculosis (MDR-TB) in Kazakhstan, where its burden is notably high.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The authors conducted a retrospective longitudinal study using the National Tuberculosis Registry, this study analyzed treatment outcomes in MDR-TB patients from 2018 to 2021, and included adult patients (\u2265\u200918 years) who completed a specific treatment. Outcomes were categorized into successful and unsuccessful treatments. Bivariate and multivariate Poisson regression models with modified errors were employed to obtain crude and adjusted risk ratios (aRR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study cohort comprised 12,698 cases, of which 10, 306 (81.16%) completed treatment with a successful outcome, while 2,392 (18.84%) had unsuccessful outcomes. Male sex (aRR 1.35, 95% CI 1.24\u20131.45), urban residency (aRR 1.16, 95% 1.07\u20131.24), having both extrapulmonary and pulmonary tuberculosis (aRR 1.49, 95% 1.04\u20132.15), XDR-TB (aRR 1.31, 95% 1.08\u20131.59), excessive alcohol consumption (aRR 1.43, 95% 1.28\u20131.59), HIV-positive status (aRR 2.24, 95% 2.01\u20132.47), and drug abuse (aRR 1.37, 95% 1.10\u20131.71) significantly elevated the risk of the unsuccessful treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings underscore the need for focused strategies to reduce the MDR-TB burden, particularly among adults, male sex, relapsed cases, and XDR-TB. Despite the encouraging findings observed, further studies are necessary to update our estimates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11547-5","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:47:20Z","timestamp":1758804440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment outcomes for drug-resistant tuberculosis: a retrospective longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruslan","family":"Akhmedullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbanu","family":"Algazyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0410nar","family":"Rakisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnaz","family":"Mussabekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnur","family":"Zhakhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Tursynbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduzhappar","family":"Gaipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Adenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulahmet","family":"Erimbetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakhimurat","family":"Ismailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"11547_CR1","volume-title":"Tuberculosis","author":"WHO","year":"2023","unstructured":"WHO. Tuberculosis. World Health Organization; 2023."},{"key":"11547_CR2","volume-title":"Global Tuberculosis Report","author":"WHO","year":"2022","unstructured":"WHO. Global Tuberculosis Report 2022. World Health Organization; 2022."},{"issue":"1","key":"11547_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15553-7","volume":"23","author":"Y Lei","year":"2023","unstructured":"Lei Y, Wang J, Wang Y, Xu C. Geographical evolutionary pathway of global tuberculosis incidence trends. BMC Public Health. 2023;23(1): 755.","journal-title":"BMC Public Health"},{"issue":"3","key":"11547_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0038-1651492","volume":"39","author":"P Glaziou","year":"2018","unstructured":"Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2018;39(3):271\u201385.","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"11547_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074208","volume":"13","author":"Y Sakko","year":"2023","unstructured":"Sakko Y, Madikenova M, Kim A, Syssoyev D, Mussina K, Gusmanov A, et al. Epidemiology of tuberculosis in Kazakhstan: data from the unified National electronic healthcare system 2014\u20132019. BMJ Open. 2023;13(10): e074208.","journal-title":"BMJ Open"},{"issue":"2","key":"11547_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017798","volume":"5","author":"P Glaziou","year":"2014","unstructured":"Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med. 2014;5(2): a017798.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11547_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-64371-7_11","volume":"1019","author":"AS Dean","year":"2017","unstructured":"Dean AS, Cox H, Zignol M. Epidemiology of Drug-Resistant tuberculosis. Adv Exp Med Biol. 2017;1019:209\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"11547_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.683515","volume":"12","author":"A Daniyarov","year":"2021","unstructured":"Daniyarov A, Molkenov A, Rakhimova S, Akhmetova A, Yerezhepov D, Chingissova L, et al. Genomic analysis of multidrug-resistant Mycobacterium tuberculosis strains from patients in Kazakhstan. Front Genet. 2021;12: 683515.","journal-title":"Front Genet"},{"issue":"1","key":"11547_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58080-0","volume":"14","author":"LW Limenh","year":"2024","unstructured":"Limenh LW, Kasahun AE, Sendekie AK, Seid AM, Mitku ML, Fenta ET, et al. Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta town, Northwest ethiopia: a five-year retrospective study. Sci Rep. 2024;14(1): 7695.","journal-title":"Sci Rep"},{"issue":"26","key":"11547_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016071","volume":"98","author":"L Sadykova","year":"2019","unstructured":"Sadykova L, Abramavi\u010dius S, Maimakov T, Berikova E, Kurakbayev K, Carr NT, et al. A retrospective analysis of treatment outcomes of drug-susceptible TB in Kazakhstan, 2013\u20132016. Medicine (Baltimore). 2019;98(26): e16071.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"11547_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05413-0","volume":"20","author":"M Darisheva","year":"2020","unstructured":"Darisheva M, Tracy M, Terlikbayeva A, Zhussupov B, Schluger N, McCrimmon T. Knowledge and attitudes towards ambulatory treatment of tubercul\u043esis in Kazakhstan. BMC Health Serv Res. 2020;20(1): 563.","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"11547_CR12","first-page":"335","volume":"49","author":"T Maimakov","year":"2013","unstructured":"Maimakov T, Sadykova L, Kalmataeva Z, Kurakpaev K, \u0160migelskas K. Treatment of tuberculosis in South kazakhstan: clinical and economical aspects. Med (Kaunas). 2013;49(7):335\u201340.","journal-title":"Med (Kaunas)"},{"key":"11547_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2022.104950","volume":"170","author":"A Gusmanov","year":"2023","unstructured":"Gusmanov A, Zhakhina G, Yerdessov S, Sakko Y, Mussina K, Alimbayev A, et al. Review of the research databases on population-based registries of unified electronic healthcare system of Kazakhstan (UNEHS): possibilities and limitations for epidemiological research and real-world evidence. Int J Med Inf. 2023;170: 104950.","journal-title":"Int J Med Inf"},{"key":"11547_CR14","volume-title":"Tuberculosis of the respiratory system in adults 2022","author":"MoH","year":"2022","unstructured":"MoH. Tuberculosis of the respiratory system in adults 2022 [Available from: http:\/\/surl.li\/uesxy"},{"key":"11547_CR15","unstructured":"MoH. Tuberculosis of the respiratory system with drug resistance in adults. 2022. [Available from: http:\/\/surl.li\/uesyg"},{"key":"11547_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00804-2021","author":"NN Linh","year":"2021","unstructured":"Linh NN, Viney K, Gegia M, Falzon D, Glaziou P, Floyd K, et al. World health organization treatment outcome definitions for tuberculosis: 2021 update. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.00804-2021.","journal-title":"Eur Respir J"},{"issue":"8","key":"11547_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","volume":"49","author":"GW Sun","year":"1996","unstructured":"Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49(8):907\u201316.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"11547_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","volume":"60","author":"G Heinze","year":"2018","unstructured":"Heinze G, Wallisch C, Dunkler D. Variable selection - a review and recommendations for the practicing statistician. Biom J. 2018;60(3):431\u201349.","journal-title":"Biom J"},{"issue":"9","key":"11547_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/aje\/kwn217","volume":"168","author":"MJ Knol","year":"2008","unstructured":"Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol. 2008;168(9):1073\u201381.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"11547_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/09622802241254220","volume":"33","author":"Y Hagiwara","year":"2024","unstructured":"Hagiwara Y, Matsuyama Y. Goodness-of-fit tests for modified Poisson regression possibly producing fitted values exceeding one in binary outcome analysis. Stat Methods Med Res. 2024;33(7):1185\u201396.","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"11547_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"11547_CR22","volume-title":"Global tuberculosis report","author":"Organization TWH","year":"2023","unstructured":"Organization TWH. Global tuberculosis report 2023: https:\/\/www.who.int\/publications\/i\/item\/9789240083851"},{"key":"11547_CR23","volume-title":"WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025: background document","author":"World Health O","year":"2021","unstructured":"World Health O. WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025: background document. Geneva: World Health Organization; 2021."},{"issue":"1","key":"11547_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4201-2","volume":"19","author":"BJ Klotoe","year":"2019","unstructured":"Klotoe BJ, Kacimi S, Costa-Conceic\u00e3o E, Gomes HM, Barcellos RB, Panaiotov S, et al. 2019 Genomic characterization of MDR\/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2\/Beijing 94\u201332 central Asian\/Russian clusters. BMC Infect Dis. 19(1): 553.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11547_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5588\/ijtld.17.0498","volume":"22","author":"A Tr\u00e9bucq","year":"2018","unstructured":"Tr\u00e9bucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, et al. 2018 Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries. Int J Tuberc Lung Dis. 22(1):17\u201325.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11547_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01350-2018","author":"NR Gandhi","year":"2018","unstructured":"Gandhi NR, Brust JCM, Shah NS. A new era for treatment of drug-resistant tuberculosis. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.01350-2018.","journal-title":"Eur Respir J"},{"key":"11547_CR27","doi-asserted-by":"crossref","unstructured":"Ahmad Khan F, Salim MAH, du Cros P, Casas EC, Khamraev A, Sikhondze W et al. 2017 Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses. Eur Respir J. 50(1).","DOI":"10.1183\/13993003.00061-2017"},{"issue":"Suppl 1","key":"11547_CR28","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","volume":"130","author":"E Vanino","year":"2023","unstructured":"Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, et al. 2023 Update of drug-resistant tuberculosis treatment guidelines: A turning point. Int J Infect Dis.130(Suppl 1):S12\u20135.","journal-title":"Int J Infect Dis"},{"key":"11547_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1136094","volume":"10","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Chen J, Ying M, Liu L, Li M, Lu S, et al. Factors associated with loss to follow-up before and after treatment initiation among patients with tuberculosis: a 5-year observation in China. Front Med. 2023;10: 1136094.","journal-title":"Front Med"},{"issue":"4","key":"11547_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3201\/eid3004.231732","volume":"30","author":"VN Dahl","year":"2024","unstructured":"Dahl VN, Butova T, Rosenthal A, Grinev A, Gabrielian A, Vashakidze S, et al. Drug-resistant tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017\u20132022. Emerg Infect Dis. 2024;30(4):831\u20133.","journal-title":"Emerg Infect Dis"},{"key":"11547_CR31","unstructured":"Organization TWH. World Health Organization & Stop TB Partnership. The global plan to stop TB 2011\u20132015: transforming the fight towards elimination of tuberculosis. 2010."},{"issue":"1","key":"11547_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1183\/09031936.00101814","volume":"45","author":"D Falzon","year":"2015","unstructured":"Falzon D, Mirzayev F, Wares F, Baena IG, Zignol M, Linh N, et al. Multidrug-resistant tuberculosis around the world: what progress has been made? Eur Respir J. 2015;45(1):150\u201360.","journal-title":"Eur Respir J"},{"issue":"1","key":"11547_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76721-2","volume":"14","author":"A Kalizhanova","year":"2024","unstructured":"Kalizhanova A, Yerdessov S, Sakko Y, Tursynbayeva A, Kadyrov S, Gaipov A, et al. Modeling tuberculosis transmission dynamics in Kazakhstan using SARIMA and SIR models. Sci Rep. 2024;14(1): 24824.","journal-title":"Sci Rep"},{"issue":"3","key":"11547_CR34","doi-asserted-by":"publisher","first-page":"e201965","DOI":"10.1001\/jamanetworkopen.2020.1965","volume":"3","author":"AA Mitani","year":"2020","unstructured":"Mitani AA, Haneuse S. Small data challenges of studying rare diseases. JAMA Netw Open. 2020;3(3):e201965.","journal-title":"JAMA Netw Open"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11547-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:47:23Z","timestamp":1758804443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11547-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11547"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11547-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted with accordance with the Declaration of Helsinki, and was approved by the Local Bioethics Commission \u2116 3 of the National Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan dated August 28, 2024, with the exception of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1125"}}